La Chaux-de-Fonds, Switzerland

Jeremy Loyau

USPTO Granted Patents = 3 

Average Co-Inventor Count = 7.5

ph-index = 1


Company Filing History:


Years Active: 2020-2025

Loading Chart...
3 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Jeremy Loyau

Introduction

Jeremy Loyau is a notable inventor based in La Chaux-de-Fonds, Switzerland. He has made significant contributions to the field of immunology, particularly through his innovative patents. With a total of 3 patents, Loyau's work focuses on developing novel therapeutic approaches for various diseases.

Latest Patents

One of Loyau's latest patents involves the development of CD47-CD38 bispecific antibodies. These novel bispecific heterodimeric immunoglobulins target both the human CD47 antigen and the human CD38 antigen. This invention is particularly relevant for treating autoimmune and proliferative diseases, including cancers such as hematologic malignancies and solid tumors. Another significant patent relates to antibodies that specifically bind to human IL1RAP. This invention also encompasses the use of these antibodies for diagnosing and treating human diseases.

Career Highlights

Throughout his career, Jeremy Loyau has worked with several prominent companies in the biotechnology sector. Notable among these are Ichnos Sciences SA and Igi Therapeutics SA. His work in these organizations has contributed to advancing research and development in therapeutic solutions.

Collaborations

Loyau has collaborated with various professionals in his field, including Marie-Agnes Doucey and Stanislas Blein. These collaborations have further enriched his research and innovation efforts.

Conclusion

Jeremy Loyau's contributions to immunology through his patents and collaborations highlight his role as a significant inventor in the field. His innovative approaches continue to pave the way for advancements in medical treatments.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…